The IBN SINA Pharmaceutical Industry PLC (DSE:IBNSINA)
322.30
-1.60 (-0.49%)
At close: Jan 22, 2026
The IBN SINA Pharmaceutical Industry Employees
The IBN SINA Pharmaceutical Industry had 5,200 employees as of June 30, 2025. The number of employees increased by 1,000 or 23.81% compared to the previous year.
Employees
5,200
Change (1Y)
1,000
Growth (1Y)
23.81%
Revenue / Employee
2.47M BDT
Profits / Employee
148.03K BDT
Market Cap
10.07B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 5,200 | 1,000 | 23.81% |
| Jun 30, 2024 | 4,200 | 200 | 5.00% |
| Jun 30, 2023 | 4,000 | 0 | - |
| Jun 30, 2022 | 4,000 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| The ACME Laboratories | 9,025 |
| Renata | 8,366 |
| Navana Pharmaceuticals | 4,798 |
| Beacon Pharmaceuticals | 4,162 |
| Orion Pharma | 2,954 |
| Techno Drugs | 1,438 |
| Beximco Pharmaceuticals PLC. | 1,122 |
| Asiatic Laboratories | 737 |